Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 730 participants.
Also called NCT01412164
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 730 participants
- Registry
-
NCT01412164
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01412164. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2016-03-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)
- Condition
- Coronary Artery Disease
- Intervention (Device)
- FIREHAWK biodegradable polymer rapamycin-eluting stent
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Record details
- Record id
cardio:ct-nct01412164- Content hash
7ca204722fb1a523ce15af4dd800caab285bae181a3cbd06bf57987d72aae021